Jacob Ellegood

Jacob Ellegood

Auto-generated profile, based on publicly available information

Jacob Ellegood

Mouse Imaging Centre, The Hospital for Sick Children, Toronto, ON, Canada

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2017 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
CSCatherine J. Stoodley
Catherine J. Stoodley
ADAnila M. D’mello
Anila M. D’mello
JEJacob Ellegood
Jacob Ellegood
VJVikram Jakkamsetti
Vikram Jakkamsetti
PLPei Liu
Pei Liu
PTPeter T. Tsai
Peter T. Tsai

13 July 2020 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
EKElyza Kelly
Elyza Kelly
FMFantao Meng
Fantao Meng
HFHirofumi Fujita
Hirofumi Fujita
FMFelipe Morgado
Felipe Morgado
YKYasaman Kazemi
Yasaman Kazemi
PTPeter T. Tsai
Peter T. Tsai

21 February 2018 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
MRMelanie Richter
Melanie Richter
NMNadeem Murtaza
Nadeem Murtaza
RSRobin Scharrenberg
Robin Scharrenberg
SWSean H. White
Sean H. White
OJOle Johanns
Ole Johanns
FAFroylan Calderon de Anda
Froylan Calderon de Anda
Atypical brain connectivity is a major contributor to the pathophysiology of neurodevelopmental disorders (NDDs) including autism spectrum disorders (ASDs). TAOK2 is one of several genes in the 16p11.2 microdeletion region, but whether it contributes to NDDs is unknown. We performed behavioral analysis on Taok2 heterozygous (Het) and knockout (KO) mice and found gene dosage-dependent impairments in cognition, anxiety, and social interaction. Taok2 Het and KO mice also have dosage-dependent abnormalities in brain size and neural connectivity in multiple regions, deficits in cortical layering, dendrite and synapse formation, and reduced excitatory neurotransmission. Whole-genome and -exome sequencing of ASD families identified three de novo mutations in TAOK2 and functional analysis in mice and human cells revealed that all the mutations impair protein stability, but they differentially impact kinase activity, dendrite growth, and spine/synapse development. Mechanistically, loss of Taok2 activity causes a reduction in RhoA activation, and pharmacological enhancement of RhoA activity rescues synaptic phenotypes. Together, these data provide evidence that TAOK2 is a neurodevelopmental disorder risk gene and identify RhoA signaling as a mediator of TAOK2-dependent synaptic development.

13 August 2018 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
HJHwajin Jung
Hwajin Jung
HPHaram Park
Haram Park
YCYeonsoo Choi
Yeonsoo Choi
HKHyojin Kang
Hyojin Kang
ELEunee Lee
Eunee Lee
EKEunjoon Kim
Eunjoon Kim

11 August 2021 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
VZValerio Zerbi
Valerio Zerbi
MPM. Pagani
M. Pagani
MMM. Markicevic
M. Markicevic
MMM. Matteoli
M. Matteoli
DPD. Pozzi
D. Pozzi
NWN. Wenderoth
N. Wenderoth
Autism Spectrum Disorder (ASD) is characterized by substantial, yet highly heterogeneous abnormalities in functional brain connectivity. However, the origin and significance of this phenomenon remain unclear. To unravel ASD connectopathy and relate it to underlying etiological heterogeneity, we carried out a bi-center cross-etiological investigation of fMRI-based connectivity in the mouse, in which specific ASD-relevant mutations can be isolated and modeled minimizing environmental contributions. By performing brain-wide connectivity mapping across 16 mouse mutants, we show that different ASD-associated etiologies cause a broad spectrum of connectional abnormalities in which diverse, often diverging, connectivity signatures are recognizable. Despite this heterogeneity, the identified connectivity alterations could be classified into four subtypes characterized by discrete signatures of network dysfunction. Our findings show that etiological variability is a key determinant of connectivity heterogeneity in ASD, hence reconciling conflicting findings in clinical populations. The identification of etiologically-relevant connectivity subtypes could improve diagnostic label accuracy in the non-syndromic ASD population and paves the way for personalized treatment approaches.

16 August 2021 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
CVClaire Marie Vacher
Claire Marie Vacher
HLHelene Lacaille
Helene Lacaille
JOJiaqi J. O’rEilly
Jiaqi J. O’rEilly
JSJacquelyn Salzbank
Jacquelyn Salzbank
DBDana Bakalar
Dana Bakalar
APAnna A. Penn
Anna A. Penn
Compromised placental function or premature loss has been linked to diverse neurodevelopmental disorders. Here we show that placenta allopregnanolone (ALLO), a progesterone-derived GABA-A receptor (GABAAR) modulator, reduction alters neurodevelopment in a sex-linked manner. A new conditional mouse model, in which the gene encoding ALLO’s synthetic enzyme (akr1c14) is specifically deleted in trophoblasts, directly demonstrated that placental ALLO insufficiency led to cerebellar white matter abnormalities that correlated with autistic-like behavior only in male offspring. A single injection of ALLO or muscimol, a GABAAR agonist, during late gestation abolished these alterations. Comparison of male and female human preterm infant cerebellum also showed sex-linked myelination marker alteration, suggesting similarities between mouse placental ALLO insufficiency and human preterm brain development. This study reveals a new role for a placental hormone in shaping brain regions and behaviors in a sex-linked manner. Placental hormone replacement might offer novel therapeutic opportunities to prevent later neurobehavioral disorders.